vMIP-II (1-21), a peptide sourced from viral macrophage inflammatory protein-II (vMIP-II), exhibits exclusive chemokine receptor antagonism by specifically engaging receptors implicated in immunological reactions. Its remarkable anti-inflammatory attributes make vMIP-II (1-21) a compelling candidate for biomedical investigations concerning the modulation of chemokine receptors across diverse pathological conditions, encompassing autoimmune maladies, inflammatory-linked malignancies, and viral afflictions.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.